ClinicalTrials.Veeva

Menu

Discontinuation Rate Among Copper IUD Users

N

noha mohamed elzaydy

Status

Unknown

Conditions

Contraceptive Device; Intrauterine

Treatments

Device: Cu-IUD

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The intrauterine device (IUD) is one of the most widely used reversible, long-term contraceptive methods in the world. But despite all its advantages; discontinuation rate of IUD ranged from 9.6% to 37.3 % (according to Demographic and Health Surveys data). In Egypt, in 2014, the discontinuation rate of IUD (within 12 months of use) was 14.3%.This study explores the differences around this rate in Egyptian university clinic and primary healthcare clinic with detailed percentages of possible causes.

Full description

The aim of the study is to compare between primary health care unit and university family planning clinic in discontinuation rate among copper IUD users.

  1. The Research Hypothesis: (Null hypothesis)

    • In women using copper IUD, discontinuation rate in primary health care unit and university clinic may be similar.

  2. The Research Question:

    • In women using copper IUD, Does discontinuation rate in primary health care unit and university clinic differ?

  3. METHODOLOGY:

Patients and Methods

• Study setting:

  • Family planning Outpatient clinic of Ain Shams Maternity Hospital, (ASUMH)

  • primary health care unit in ain shams area

    • Study population:

  • Study period: 1 year

  • Sample size: was calculated using Sample size computer program 11. After review of literature, no previous similar study was done before, so assume a discontinuation rate of 50% among Cu-IUD users in primary healthcare unit and 25% among Cu-IUD users in university clinic. Based on these values; the study will include 170 Cu-IUD users; equally selected as 85 subjects from each clinic. But due to the expected drop outs, recruitment will start by 200 women from each clinic.

    • Statistics:

      • Descriptive statistics for measured variables will be expressed as range, mean and standard deviation (for metric data); range, median and interquartile range (for discrete data); and number and proportions (for categorical data). Cu-IUD discontinuation findings in each clinic will be compared using the t-test or the Mann-whitney U test depending on whether the measured parameters are guassian variables. A P-value of 0.05 or less will be considered statistically significant.

Enrollment

400 estimated patients

Sex

Female

Ages

18 to 49 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

    1. Age from 18-49 years. 2. Women planning for Cu-IUD insertion as a contraceptive method.

Exclusion criteria

    1. Any woman with condition included in Category 3 or 4 for Cu-IUD in medical eligibility criteria for contraceptive use (MEC) -World Health Organization-2015.

Trial design

400 participants in 2 patient groups

university clinic
Description:
* Enrollment: 200 Subjects will be enrolled from women attending family planning clinic for Cu- IUD insertion * Informed Consent: All participants will give their informed consent prior to enrollment. * Data collection \& recording: Data of each patient will be recorded in a Case Record Form (CRF). * Follow up visits /questionnaire: will be conducted from each subject at 6 months and 12 months after Cu-IUD insertion. User satisfaction score and haemoglobin serum level will be included in the questionnaire.
Treatment:
Device: Cu-IUD
primary healthcare unit clinic
Description:
* Enrollment: 200 Subjects will be enrolled from women attending family planning clinic for Cu- IUD insertion * Informed Consent: All participants will give their informed consent prior to enrollment. * Data collection \& recording: Data of each patient will be recorded in a Case Record Form (CRF). * Follow up visits /questionnaire: will be conducted from each subject at 6 months and 12 months after Cu-IUD insertion. User satisfaction score and haemoglobin serum level will be included in the questionnaire.
Treatment:
Device: Cu-IUD

Trial contacts and locations

1

Loading...

Central trial contact

noha elzaydy, M.B.B.Ch.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems